Navigation Links
Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
Date:3/10/2010

se factors could materially affect Cumberland's results of operations. These factors include market conditions, competition, an inability of manufacturers to produce Cumberland's products on a timely basis or a failure of manufacturers to comply with regulations applicable to pharmaceutical manufacturers, maintaining an effective sales and marketing infrastructure and other factors discussed in the Company's Registration Statement declared effective by the SEC on August 10, 2009. There can be no assurance that results anticipated by the Company will be realized or that they will have the expected effects. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof. The Company does not undertake any obligation to publicly revise these statements to reflect events after the date hereof.

    
    
    CUMBERLAND PHARMACEUTICALS INC.
    CONSOLIDATED BALANCE SHEETS
    DECEMBER 31, 2009 AND 2008
    
    ASSETS                                         2009              2008
                                                   ----              ----
    Current assets:
      Cash and cash equivalents                $78,701,682       $11,829,551
      Accounts receivable, net of allowances     6,176,585         3,129,347
      Inventories                                4,822,873         1,762,776
      Prepaid and other current assets           2,746,259           481,312
      Deferred tax assets                          726,196           507,212
                 Total current assets           93,173,595        17,710,198
    Property and equipment, net                    918,412           432,413
    Intangible assets, net                       7,956,009         8,528,732
    Deferred tax assets                          1,306,514         1,000,031
    Other assets                                   369,790    
'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
2. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
3. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... -- Lannett Company, Inc. (NYSE: LCI ) today announced ... credit facility to $120 million from $50 million.  The ... the company to increase borrowings by a total of ... additional commitments from existing lenders or new lending institutions.  ... 18, 2018.   "The amended credit facility, ...
(Date:4/24/2015)... , April 24, 2015 Hospira, Inc. ... the development of biosimilar therapies, spoke about the importance ... the European Generics Association (EGA) annual European Biosimilars Group ... The company also announced the publication of a pivotal ... achieving the full promise of biosimilars." ...
(Date:4/24/2015)... CAMBRIDGE, Mass. , April 24, 2015 /PRNewswire/ ... that BLU-554, a selective and potent inhibitor of ... anti-tumor activity in models of hepatocellular carcinoma (HCC) ... targeted therapeutic candidate, BLU-554 induced complete tumor regression ... of an FGFR4-activating ligand at the highest dose ...
Breaking Medicine Technology:Lannett Expands Revolving Credit Facility To $120 Million 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 2Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 3
... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) announced ... Finance, CFO and treasurer. Mr. Cooper, who has been with ... Company for personal reasons.  He has been commuting from the ... 2006.  Mr. Cooper will remain in his current role at ...
... 2011 Sevocity, a division of Conceptual MindWorks, Inc. ... compliant and was certified as a Complete EHR on ... Information Technology (CCHIT®), an ONC-ATCB, in accordance with the ... of Health and Human Services. The 2011/2012 criteria support ...
Cached Medicine Technology:Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer 2Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer 3Sevocity, a Division of Conceptual MindWorks, Inc's Sevocity Receives ONC-ATCB 2011/2012 Certification 2Sevocity, a Division of Conceptual MindWorks, Inc's Sevocity Receives ONC-ATCB 2011/2012 Certification 3
(Date:4/24/2015)... ON (PRWEB) April 24, 2015 ... safe, informed and legal access to medical cannabis, is ... are properly supported when advising patients. , NAC is ... Certificate Program. With a $250,000 grant, NAC will be ... program. , "Our goal is to help Canadians gain ...
(Date:4/24/2015)... 24, 2015 “ Opera ” was featured ... features the latest and coolest technology products available to consumers. ... conducted the review and shared with viewers how this is ... browsers, surfing the internet would not be in existence. But ... the Opera browser is no different. Celebrating their 20th anniversary ...
(Date:4/24/2015)... Telematics Berlin is the foremost Automotive Data ... 2 suppliers, content providers, associations and government bodies. From ... chain, see them converge in Berlin. This year’s start-up ... those companies currently at the forefront of Europe’s Silicon ... customer centric products, ParkTAG are one of the first ...
(Date:4/24/2015)... Qualis Health, one of the ... a new resource for practicing physicians, “2013 QRUR ... Quality and Resource Use Reports (QRUR) supplements resources ... (CMS) to help practices interpret their Medicare reports ... identify care coordination opportunities to provide broader support ...
(Date:4/24/2015)... York (PRWEB) April 24, 2015 PURE ... with Allergy and Asthma Network (The Network), a highly ... Solutions will provide news, tips and information for a ... Network’s newly redesigned website. , The goal for both ... about the travel needs of people with asthma and ...
Breaking Medicine News(10 mins):Health News:National Access Cannabis Gives 300 Canadian Healthcare Professionals Access to Medical Cannabis Certificate Program 2Health News:A Web Browser That Connects over 350 Million People was Featured on NewsWatch Television 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 3Health News:Qualis Health Publishes Guide to Help Physician Practices Assess and Improve Quality 2Health News:PURE Solutions Partners with Allergy and Asthma Network to Provide Allergy Travel Tips 2
... has been selected as one of 10 centers in the ... major new initiative to facilitate the discovery and development of ... Chemical Diversity Centers, Vanderbilt,s role in the consortium will be ... , "This is a real tribute to our growth in ...
... of Pittsburgh School of Medicine have shown that proteins have ... for their biological activity. This shape-changing also allows the small ... the structure that permits the best binding. That premise could ... have the most impact on protein function to better treat ...
... , White paper outlines how to maintain quality ... PLYMOUTH MEETING, Pa., Aug. 19 Physician preference items (PPIs), ... as pricey orthopedic implants and cardiovascular devices, are estimated at 60% ... and margins from both operations and pooled investments declining, many hospital ...
... , , ST. LOUIS, Aug. ... the Mission" on Aug. 15 to raise funds for the company,s ... Approximately 2,400 Reliv independent distributors from 10 countries participated ... place here from Aug. 13-15. , , ...
... 19 N2Care founder Kenneth Dupin presents the MEDcottage to the ... Sheraton Hotel Conference Theater at 2801 Hershberger Rd. in Roanoke, VA ... Kenneth Dupin is throwing down a bedpan gauntlet at the steps ... baby boomers are not going to nursing homes, not ever! On ...
... , SAN RAMON, Calif., Aug. 19 Celebrating ... Hearing Community, Purple Communications((TM)), Inc. (Nasdaq: PRPL ) will ... advocate for American Sign Language (ASL). , , ... 22, 2009 at the San Ramon Marriott, 2600 Bishop Drive in ...
Cached Medicine News:Health News:Vanderbilt joins national consortium to develop new cancer therapies 2Health News:Vanderbilt joins national consortium to develop new cancer therapies 3Health News:Pitt scientists find intrinsic changes in protein shape influence drug binding 2Health News:Wasting Millions on Purchases Based on Physician Preference White Paper Now Available From ECRI Institute 2Health News:Wasting Millions on Purchases Based on Physician Preference White Paper Now Available From ECRI Institute 3Health News:Reliv 'Walk for the Mission' Raises Approximately $47,000 for Malnourished People 2Health News:N2Care Unveils Backyard Smart MEDcottage 2Health News:Purple Communications Invites Greater San Ramon Community to Celebrate Ms. Ella Mae Lentz, Finalist in 'Dream Bigger' Initiative 2Health News:Purple Communications Invites Greater San Ramon Community to Celebrate Ms. Ella Mae Lentz, Finalist in 'Dream Bigger' Initiative 3Health News:Purple Communications Invites Greater San Ramon Community to Celebrate Ms. Ella Mae Lentz, Finalist in 'Dream Bigger' Initiative 4Health News:Purple Communications Invites Greater San Ramon Community to Celebrate Ms. Ella Mae Lentz, Finalist in 'Dream Bigger' Initiative 5
Radianse indoor positioning supports healthcare asset management with a way to locate medical equipment, devices and other portable assets....
Agility has delivered a RFID-enabled mobile asset management program....
Agility can provide tracking and management of surgical instruments, instrument trays and case carts to significantly enhance the current central sterile department flow by improving efficiency....
Assetrac allows identification, location, and protection of your assets....
Medicine Products: